Pharmaceutical company Gilead recently published research showing that lenacapavir, a new generation antiretroviral drug used to treat HIV-infected patients, is 100% effective in preventing the disease of the century if given 2 injections per year. .

According to the report, the drug is 100% effective in preventing HIV infection in women and is almost equally effective in men.

Gilead said it will sell the low-cost drug in 120 poor countries with high HIV infection rates – mainly in Africa, Southeast Asia and the Caribbean.

Evaluating this drug, Executive Director of the United Nations Program on HIV/AIDS (UNAIDS) Winnie Byanyima said that this therapy is far superior to any other prevention method today.

Grandma.

The drug lenacapavir is sold under the brand name Sunlenca to treat HIV in the US, Canada and Europe.

This measure not only helps prevent the disease of the century, but also has humanitarian significance in helping people at high risk such as gay people reduce discrimination because they only have to go to medical facilities twice a year. to inject medicine. instead register with government programs and receive daily preventative medications.

In a report published on World AIDS Day on December 1, UNAIDS said the world will record 630,000 deaths from the disease of the century in 2023, the lowest level since the peak in 2004.

This achievement is an important milestone, showing that the world has a chance to end this pandemic./.